ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)

CUSIP: 82835W108

Q2 2024 13F Holders as of 30 Jun 2024

Holder snapshot 7 signals
Share change
+2,642,192
Put/Call ratio
6.1%
SEC-reported price per share
$8.51
Number of holders
112
Value change
+$21,909,612
Number of buys
65
Open additional details 1 more signal available
Number of sells
45
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
100,837,480

Security key

82835W108

Report period

Q2 2024

Institutions

112

Top holders

10

Ownership snapshot

Top reported holders of SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
DEERFIELD MANAGEMENT COMP...
Disclosed value leader
DEERFIELD MANAGEMENT COMP...
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F Lead comparable stake: 11% Showing 1-6 of 15 holder rows.

Quick read

DEERFIELD MANAGEMENT COMPANY, L.P. leads the comparable SEC ownership view at 11%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens DEERFIELD MANAGEMENT COMPANY, L.P.'s linked filing trail.
Comparable ownership Top 5
DEERFIELD MANAGEMENT COMPANY, L.P. 11%
RA CAPITAL MANAGEMENT, L.P. 11%
ORBIMED ADVISORS LLC 9.2%
SR ONE CAPITAL MANAGEMENT, LP 4%
FRANKLIN RESOURCES INC 2.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
13F
11%
$113,216,414
11,077,927 shares
31 Mar 2024
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
11%
$110,999,185
10,860,977 shares
31 Mar 2024
ORBIMED ADVISORS LLC
13F
Company
13F
9.2%
$94,441,865
9,240,887 shares
31 Mar 2024
SR ONE CAPITAL MANAGEMENT, LP
13F
Company
13F
4%
$41,011,869
4,012,903 shares
31 Mar 2024
FRANKLIN RESOURCES INC
13F
Company
13F
2.9%
$30,158,842
2,950,963 shares
31 Mar 2024
VANGUARD GROUP INC
13F
Company
13F
2.9%
$29,499,570
2,886,455 shares
31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
112
Shares
62,590,275
Rows available
112
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
113
Q2 2024 holders
112
Holder diff
-1
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .